Ep. 176: Hormone Replacement Therapy & Menopause Misconceptions
Listen, Rate & Subscribe*
Apple Podcasts // Spotify // Google Podcasts // Stitcher // Amazon Music // YouTube
Dr. Jennifer Zelovitzky is the clinical director of women’s health and vitality at Medcan and leads the new perimenopause and menopause program. She’s a certified menopause practitioner and an advocate for the benefits of hormone replacement therapy. Dr. Zelovitzky also has an unusual backstory that includes working on Bay Street before attending medical school while raising two young daughters. Here, she joins Director of Clinical Innovation Allison Hazell to talk about menopause misconceptions, the education gap that exists around women’s health—and how Medcan’s new program aims to empower women with knowledge.
LINKS
To learn more about Medcan’s perimenopause and menopause program, contact 416.350.5900 or email clientservice@medcan.com.
Menopause costs U.S. Women $1.8 billion in lost working time, study shows.
New menopause treatments offer hope for women with dwindling options: Globe and Mail.
How perimenopause and menopause can alter women’s menstrual cycle, from the New York Times. Plus, from the paper’s Sunday magazine: Women Have Been Misled About Menopause.
The Women's Health Initiative hormone therapy study that Dr. Zelovitzky mentions as a main reason why medical practitioners believed that HRT increases risk of chronic disease.
Dr. Zelovitzky is a certified menopause practitioner. Learn more about the certification and the North American Menopause Society.
Previous women’s health episodes:
Ep. 159: A Woman’s Guide to Preventive Health with Dr. Vivien Brown
Ep. 141: Spotlight on Women’s Health with Dr. Vivien Brown
INSIGHTS
02:28 Dr. Jennifer Zelovitzky’s journey: from a career in finance on Bay Street to clinical director of women’s health and vitality at Medcan
09:14 Healthcare needs to be doing more for women’s health
10:47 How we’re changing the way women’s health challenges have been stigmatized.
13:40 How much training do family physicians receive on menopause and perimenopause care?
14:30 How old are you when you enter perimenopause? Which symptoms of menopause are considered “normal,” and which warrant treatment with hormone therapy or medication?
17:00 A breakdown of the Perimenopause and Menopause Program: a 6-month multidisciplinary clinic that Dr. Zelovitzky and her team have been working hard to develop.
21:26 Hormone replacement therapy: what is it, and why has it historically been incorrectly considered to increase risk of chronic disease.
24:50 Who is a good fit for hormone replacement therapy, and what does the process at Medcan look like from a patient’s perspective?
28:00 Dr. Zelovitzky talks through the biggest misconceptions she’s heard about hormone replacement therapy.
Clinical Director of Women’s Health and Vitality, Dr. Jennifer Zelovitzky, (left) and Allison Hazell, Director of Clinical Innovation
*LEGAL
This podcast episode is intended to provide general information about health and wellness only and is not designed, or intended to constitute, or be used as a substitute for, medical advice, treatment or diagnosis. You should always talk to your Medcan health care provider for individual medical advice, diagnosis and treatment, including your specific health and wellness needs.
The podcast is based on the information available at the time of preparation and is only accurate and current as of that date. Source information and recommendations are subject to change based on scientific evidence as it evolves over time. Medcan is not responsible for future changes or updates to the information and recommendations, and assumes no obligation to update based on future developments.
Reference to, or mention of, specific treatments or therapies, does not constitute or imply a recommendation or endorsement. The links provided within the associated document are to assist the reader with the specific information highlighted. Any third-party links are not endorsed by Medcan.